Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Octopus Biosafety's Enterprise Value is €20.86 Mil.
Octopus Biosafety's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil. Therefore, Octopus Biosafety's EV-to-EBIT ratio for today is -24.93.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Octopus Biosafety's Enterprise Value is €20.86 Mil.
Octopus Biosafety's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil. Therefore, Octopus Biosafety's EV-to-EBITDA ratio for today is -24.93.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Octopus Biosafety's Enterprise Value is €20.86 Mil.
Octopus Biosafety's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.05 Mil. Therefore, Octopus Biosafety's EV-to-Revenue ratio for today is 401.23.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Octopus Biosafety (STU:OCR) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Octopus Biosafety's current Enterprise Value is €20.86 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Octopus Biosafety's current Enterprise Value is €20.86 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.84 Mil.
Octopus Biosafety's current Enterprise Value is €20.86 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.05 Mil.
Octopus Biosafety's current Enterprise Value is €20.86 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.
Octopus Biosafety's current Enterprise Value is €20.86 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Octopus Biosafety's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety Enterprise Value Related Terms
Octopus Biosafety Enterprise Value Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OCR vs SNDK, DELL, STX: Enterprise Value Comparison
For the Computer Hardware subindustry, Octopus Biosafety's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Enterprise Value vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Octopus Biosafety's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a Enterprise Value of €20.86 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Octopus Biosafety and its competitors.
Is Octopus Biosafety's Enterprise Value too high?
Octopus Biosafety's current Enterprise Value is €20.86 Mil. Overall, Octopus Biosafety has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Enterprise Value compare to SNDK and DELL?
Octopus Biosafety's Enterprise Value of €20.86 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Hardware company?
A good Enterprise Value depends on the Hardware industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Octopus Biosafety and its competitors. Octopus Biosafety's current Enterprise Value is €20.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Enterprise Value of €20.86 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Enterprise Value is €20.86 Mil. Octopus Biosafety's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Enterprise Value is €20.86 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.
Key valuation signals for STU:OCR:
Enterprise Value: €20.86 Mil
GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
11GF Score
Get the complete analysis for STU:OCR
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
